Introduction
African horse sickness (AHS) is caused by African horse sickness virus (AHSV), which belongs to the genus Orbivirus, family Reoviridae. AHS is a non-contagious disease of equids, transmitted by Culicoides midges (Diptera: Ceratopogonidae). In the equine host, the virus replicates in endothelial cells and macrophages, and causes vascular injury that can result in four clinical forms of AHS, i.e. pulmonary (dunkop), cardiac (dikkop), mixed and horse sickness fever forms (Guthrie and Quan, 2009 ).
AHS is an OIE-listed disease because of its associated high mortality and potential for rapid international spread (OIE, 2005 ). An outbreak of AHS in a naïve horse population can be devastating, with cumulative mortality of up to 95% (Guthrie and Quan, 2009; Mirchamsy and Hazrati, 1973) . The disease is endemic to sub-Saharan Africa and outbreaks have been reported recently in Ethiopia, Senegal, Ghana, Nigeria and southern Africa to the World Organisation for Animal Health (OIE). AHS has spread previously from the African continent to Europe in 1966 and 1987 to 1990 (Díaz-Montilla and Paños Martí, 1967 Rodriguez et al., 1992) , as well as to the Middle East/south west Asia on several occasions (Alexander, 1948; Anderson et al., 1989; Howell, 1960; Reid, 1961) . There is concern currently regarding the potential for AHS to re-emerge from Africa because of the effects of climate change (Dufour et al., 2008; Gale et al., 2010) . Climate change has been proposed to be responsible for the recent spread of bluetongue virus into Europe from Africa and Asia (Purse et al., 2005) .
Accurate diagnostic assays i) demonstrate freedom from infection in a defined population, ii) certify freedom from infection or agent in individual animals or products, iii) assist in eradication of infection from a defined population or, iv) confirm diagnosis of suspect or clinical cases (OIE, 2008) . For all purposes, accurate diagnosis of AHSV is essential due to the severe nature of the disease and the implications of a false negative result. A rapid assay is desirable, and compared to traditional viral isolation techniques, molecular methods based on the reverse transcription polymerase chain reaction (RT-PCR) have dramatically shortened the time required to identify pathogens.
The majority of previously published AHSV assays are based on visualisation of the PCR product on an agarose gel. They have been designed to target either the VP3 4 (L3) (Aradaib, 2009; Aradaib et al., 2006; Sakamoto et al., 1994) , VP7 (S8) (Moulay et al., 1995; Sailleau et al., 1997; Zientara et al., 1993; Zientara et al., 1994; Zientara et al., 1995b; Zientara et al., 1998) , NS1 (M5) (Mizukoshi et al., 1994) , NS2 (S9) (Bremer and Viljoen, 1998; Stone-Marschat et al., 1994) or NS3 (S10) (Zientara et al., 1995a; Zientara et al., 1995b) gene. With real-time RT-PCR, the PCR product is detected in "real time". The advantages over gel-based assays are an increased analytical sensitivity and a more rapid assay with less potential for contamination.
Real-time RT-PCR assays for AHSV have been published recently and target either the VP7 (Agüero et al., 2008; Fernández-Pinero et al., 2009) or NS1 (RodriguezSanchez et al., 2008) gene.
This paper describes the development and optimisation of a duplex real-time reverse transcription quantitative PCR (RT-qPCR) assay for the sensitive and specific detection of AHSV in blood samples from horses naturally infected with the virus.
None of the previously published AHSV assays have been optimised for the detection of AHSV in blood samples from naturally infected horses. Detection of AHSV in blood, rather than from tissue culture, is more challenging, due to the presence of PCR inhibitors (e.g. haemoglobin) and the low concentration of AHSV in the blood of some infected horses. The assay is novel in that it targets both the VP7 and NS2 genes of AHSV and is quantitative. Critical control parameters of the assay, as well as the repeatability, analytical sensitivity and specificity of the assay were estimated.
Material and Methods

Sequencing
AHSV was isolated from 52 samples submitted in 2004 and 2005 to the Equine Virology Research Laboratory, Department of Veterinary Tropical Diseases (DVTD),
Faculty of Veterinary Science, University of Pretoria, by culture on BHK-21 cells and typed by the plaque inhibition neutralization test (Quan et al., 2008) . Nine reference strains (designated as "Jane" 1-9), derived from virulent field viruses and representing each AHSV serotype (one to nine), were included in the isolates selected for sequencing. Terminal primers for the VP7 (Zientara et al., 1993) , NS1
and NS2 genes were designed with the aid of FastPCR 5.2.12 (Table 1a) and sequences available on the National Center for Biotechnology Information's GenBank website (www.ncbi.nlm.nih.gov). RT-PCR and direct sequencing of the 5 PCR product were performed as described previously (Quan et al., 2008) . Phred (Ewing et al., 1998; Ewing and Green, 1998) and the Staden package (Staden, 1996; Staden et al., 2000) were used for base calling and sequence assembly. Sequences were aligned using MAFFT (Katoh et al., 2002; Katoh et al., 2005) , conserved regions identified with the use of quality scores in ClustalX ( Figure 1 ) and PrimerExpress 2.0 (Applied Biosystems, Foster City, USA) software used to design primers and TaqMan ® MGB™ hydrolysis probes. Pairwise genetic distances were calculated from nucleotide substitution models determined using Modeltest v3.7
(Posada and Crandall, 1998) and PAUP* v4b10 (Swofford, 2003) .
Optimisation
All steps of the assay, i.e. processing of the blood samples, RNA extraction, RT and PCR were optimised (details supplied in supplementary information 
AHSV standard dsRNA
The VP7 and NS2 PCR products from the real-time RT-PCR assay were purified using a QIAquick ® PCR Purification Kit (Qiagen), cloned using the pGEM ® -T Easy
Vector System II (Promega, Madison, USA), according to the manufacturer's 6 instructions and sequenced using T7 and SP6 primers to determine the orientation of the insert and to check for sequence differences (Quan et al., 2008 were combined, heated to 95°C for two min and cooled to room temperature to form dsRNA. Aliquots of a ten-fold dilution series of 10 8 to 10 0 dsRNA copies/μl were prepared using TE buffer (Ambion) as a diluent and stored at -80°C until needed.
Within-and between-day repeatability of the assays
Each dilution of the VP7 and NS2 dsRNA dilution series was combined in the same well and analysed using the same protocol used for blood samples. No-RT controls were included to assess the efficiency of the DNase step in preparing the dsRNA.
The dilution series was run in triplicate on six separate days (total 18 runs). Withinday and between-day variation of the assay was assessed with analysis of variance (ANOVA) and coefficient of variation (CV).
Efficiencies of the assay, analytical sensitivity and specificity
The efficiency of each assay was calculated from the slope of the linear regression of the C T data against log dilution of the dilution series using the formula: efficiency = ] -1. Analytical sensitivity (defined as the viral copy number detected 95% of the time) of each assay was calculated from a sigmoidal regression of sensitivity against log dilution (Bhoora et al., 2009; Sibeko et al., 2008) . The sensitivity of each assay was compared to the sensitivity of AHSV isolation on BHK-21 cells (Quan et al., 2008) . Three AHSV positive tissue culture samples (serotypes six, five and two), at a concentration of 10 4.8 TCID 50 /ml, were diluted ten-fold in a dilution series up to a 7 10 -9 dilution, and 0.5 ml of each dilution tested in parallel by viral isolation on BHK-21 cells (Quan et al., 2008) and RT-qPCR. Analytical specificity of each assay was determined by testing the assay on tissue cultures of various orbiviruses (bluetongue virus, equine encephalosis virus, epizootic hemorrhagic disease virus and Palyam virus). RNA was extracted from 100 μl of tissue culture suspension of the orbivirus using the RNeasy Mini kit (Qiagen) and eluted in 50 μl water, before running the assays.
Protocol
Whole blood (500 µl) in EDTA/heparin was transferred to an eppendorf tube, frozen and thawed. The sample was vortexed briefly and spun at 15,000 g in a benchtop centrifuge for ten min, which resulted in the separation of the sample into three layers: a clear top layer, opaque middle layer and a pellet at the bottom of the tube.
Both top and middle layers were removed and 900 µl H 2 O added to the pellet. The sample was vortexed briefly, spun at 7,000 g for five min, the supernatant removed, 
Data analysis
Data were analysed with either SPSS 15.0 or 17.0 for Windows (SPSS Inc., Chicago, USA).
Results
Sequencing
The AHSV isolates that were sequenced were obtained from South Africa, Namibia and Zimbabwe. At least three AHSV isolates per serotype were sequenced and 43, 42 and 37 unique VP7, NS1 and NS2 gene sequences, respectively, were obtained (Genbank accession nos xxxx) ( Table 2) . Although the VP7, NS1 and NS2 genes were well conserved, no completely (100%) conserved region in the NS1 gene was identified. In contrast, conserved regions within the VP7 and NS2 gene were identified ( Figure 1 ) and assays targeting only the VP7 and NS2 genes and using TaqMan ® MGB™ hydrolysis probes were designed (Table1b).
The VP7, NS1 and NS2 gene sequences (together with Genbank sequences) were used to align primer and probe sequences from published AHSV assays and all the 9 assays showed mismatches in either, or both, the primer and probe regions ( Figure   2 ).
Optimisation
Details of the optimisation are provided in the supplementary information, but in brief, i) no significant difference was detected between processing fresh or frozen blood samples, ii) extraction of RNA using the RNeasy Mini Kit provided the most consistent results, iii) there was a 1.3-fold increase in amount of AHSV detected when heat (95°C), instead of methylmercury(II) hydroxide (Alfa Aesar, London, UK) was used to denature the dsRNA and significantly lower C T value's were obtained when dsRNA was denatured at 95°C for one min compared to 98°C for five min, iv) the addition of random hexamers to dsRNA before denaturation resulted in an 18-fold higher detection of AHSV (a mean decrease in C T of 4.16) compared to the addition of random hexamers after denaturation, v) the analytical sensitivity of the assays increased 100-fold when random hexamers, instead of gene-specific primers were used for RT, vi) the use of Reverse Transcription Reagents at 42°C for 30 min was determined to be the optimum kit, temperature and time for RT, vi) the TaqMan ® Fast
Universal Kit, using a final primer and probe concentration of 300 nM and 250 nM, respectively, was the optimum kit and concentration of primers and probe for PCR, and vii) significantly lower C T 's (mean difference of 0.33 for the VP7 assay and 0.22
for the NS2 assay) were obtained when the assay was run as a singleplex compared to a duplex assay.
Standard curve
The DNA concentration in the RNA standard was approximately 10 4.6 (38,000 or 15 C T difference) and 10 4.3 (22, 000 or 14 C T difference) times less than the RNA concentration for the VP7 and NS2 standards, respectively. DNA contamination of the RNA standard was therefore regarded as not of practical consequence.
Linear regressions of serial dilutions of AHSV RNA are shown in Figure 3 . The linear dynamic range covers six log 10 concentrations (10 2 -10 8 RNA copies) for the VP7 assay and five log 10 concentrations (10 2 -10 7 RNA copies) for the NS2 assay.
Within-and between-day repeatability of the assays
ANOVA showed no significant daily variation in the slope (p = 0.627) or intercept (p = 0.437) for the VP7 assay, but there was a significant between-run variation in slope (p = 0.010) and intercept (p = 0.044) for the NS2 assay, due to the high CV of the 10 8 AHSV RNA copies data ( Figure 4b ). A repeat of the analysis excluding these data was not significant and further calculations were carried out with these data excluded. Within-run, the lowest CV's were obtained for the high AHSV concentration samples, increasing with decreasing AHSV concentrations.
Efficiencies of the assays, analytical sensitivity and specificity
The PCR efficiencies of the VP7 and NS2 assays were 111% (σ = 0.05, n = 18) and 99% (σ = 0.06, n = 18) respectively. The analytical sensitivities of the assays were 132 (VP7) and 114 (NS2 assay) AHSV copies, or a C T -value of 36.13 and 37.71, respectively ( Figure 5 ). Calculated from the standard curve, this equates to 10 3.62
(4,125) and 10 3.55 (3,562) AHSV/ml blood for the VP7 and NS2 assays, respectively.
The VP7 and NS2 assays were both ten times (n = 3) more sensitive than viral isolation and an estimated 10 2.99 (987) AHSV particles were required to infect 50% of BHK-21 tissue culture plates (one TCID 50 ). The assays were specific, as fluorescence above the threshold (0.1) was detected for all nine serotypes of AHSV within 40 PCR cycles, but not for other orbiviruses (Table 3) .
Serial sampling of an AHSV infected horse
AHSV viraemia was first detected seven days post-inoculation. The amount of AHSV in the blood increased rapidly and a peak viraemia of 10 6.89 AHSV RNA/ml blood was detected 15 days post inoculation ( Figure 6 ). AHSV dsRNA was present in the blood for up to 97 days post-inoculation, at a concentration that could be detected 95% of the time for up to 51 days post-inoculation.
Discussion
The real-time RT-PCR assay described is unique in that it is designed from the sequences of current circulating field strains of AHSV. Sequencing of southern African AHSV isolates showed that the NS2 gene was the most conserved gene of the three genes that were evaluated (VP7, NS1, NS2), as judged by the median pairwise genetic distance between sequences, followed in order by the NS1 and VP7 genes. All three genes were highly conserved compared to the NS3 gene, the 11 second most variable gene in the AHSV genome (Van Niekerk et al., 2003) , as the maximum variation between amino acid sequences was less than 3% for the VP7, NS1 and NS2 proteins, whereas there was as much as 36% variation between amino acid sequences of the various NS3 proteins (Table 2) .
Evaluation of sequence data obtained from southern African AHSV isolates and GenBank with published real-time RT-PCR assays showed nucleotide mismatches in the primer/probe regions, with differences in either the forward primer (Agüero et al., 2008) , probe (Fernández-Pinero et al., 2009) , or both primers and probe (RodriguezSanchez et al., 2008) . The ability of these assays to detect all southern African AHSV strains is not known, but it is possible that sensitivity for some of the assays may be reduced due to mismatches in either the centre (Fernández-Pinero et al., 2009) A protocol for the detection of AHSV in whole blood was optimised. Freezing of blood samples was convenient, as samples could be stored and batched before the assay was run and the freezing process did not result in a significant loss of template. To extract RNA from the thawed samples, the QIAamp Viral kit was the most sensitive of the extraction kits tested, however, the results were not consistent, presumably as a result of inefficient removal of PCR inhibitors such as haemoglobin from the eluate.
The QIAamp Viral kit was designed for extraction of RNA from cell-free material (serum/plasma), whereas our assay required the extraction of RNA from a cell pellet with a higher concentration of PCR inhibitors than serum/plasma. An added advantage of the RNeasy Mini kit was that the kit could also be used for extracting AHSV RNA from organ samples collected at post mortems. Thus, the RNeasy Mini kit was selected because of more consistent results that were obtained using it. It took approximately five hours to get results from 15 samples and the kit was therefore suitable for low-throughput situations, such as confirmation of an AHS diagnosis. For high-throughput situations, such as surveillance during an AHS outbreak where a large number of samples would need to be tested, automated extraction methods would need to be developed.
The step that that had the most significant effect on the sensitivity of the assay was the denaturation of dsRNA together with random hexamers. An 18-fold greater amount of AHSV was detected when dsRNA was denatured together with random hexamers. We attributed this difference to the hexamers' ability to bind to singlestranded heat-denatured RNA before the RNA had cooled sufficiently to reform 12 dsRNA. Another significant step was the use of random hexamers instead of genespecific primers for RT. Although there was not a substantial difference in C T results obtained when using either primer, the limit of detection was 100-fold greater when random hexamers were used, indicating the sensitivity of random hexamers in the RT of low concentrations of RNA. The assay is at least ten-fold more sensitive than virus isolation and specific, detecting only AHSV and no other orbiviruses.
Assessment of the repeatability of the assay showed high between-run CV's results from the high AHSV concentration samples, which may be due to inhibition of the RT or PCR by the high nucleic acid concentration or other inhibitors in these samples.
The assay is in a duplex format and therefore redundant. The redundancy insures against false-negative results due to nucleotide variation within any one of the target regions. A high degree of sequence variation of the AHSV genome can be expected because of the high mutation rate of RNA viruses (Belshaw et al., 2008; Drake et al., 1998 ). The assay is complementary to new recombinant vaccines expressing outer capsid proteins of AHSV (VP2 and VP5) (Guthrie et al., 2009) . As the assay is specific for AHSV VP7 and NS2 genes, it can differentiate infected from vaccinated animals, something that is not possible with the current use of modified live vaccines.
In summary, a rapid, analytically sensitive and specific assay for the detection of AHSV is described. In addition to providing an important new diagnostic test, the assay is quantitative and the results suitable for mathematical modelling and pathogenesis studies, which will allow for a greater understanding of AHS. Validation of the diagnostic performance of the assay with field samples is the next step to ensure its utility.
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Materials and methods
Processing blood samples
Naturally AHSV-infected whole blood (500 μl) was spun at 1,000 g in a benchtop
centrifuge for ten min. The plasma was removed and the pellet resuspended in 900 μl phosphate-buffered saline. The eppendorf was inverted a few times to mix the contents and then spun at 1,000 g for ten min. The supernatant was removed, 500 μl H 2 O added and the contents vortexed. The sample was spun at 15,000 g for ten min
and the supernatant removed. The pellet was washed in 900 μl H 2 O, spun at 7,000 g for five min and the supernatant discarded.
This method was compared to freezing blood: whole blood (500 μl) was frozen and thawed, spun at 15,000 g for ten min and the supernatant removed. The pellet was washed in 900 μl H 2 O, spun at 7,000 g for five min and the supernatant discarded. To denature dsRNA with MMOH, one μl 0.2 M MMOH was added to five μl of dsRNA and incubated for ten min at room temperature. The mixture was reduced with one μl 1 M 2-mercaptoethanol (Sigma, St Louis, USA). To denature dsRNA with heat, five μl 2 RNA was added to two μl H 2 O, heated to 98°C for five min and put immediately on ice.
RNA extraction kits
To evaluate the influence of secondary RNA structure on the efficiency of reverse transcription, the denaturation method was followed by running the reverse transcription at various temperatures. The effect of secondary RNA structure on transcription would be more evident at lower temperatures. TaqMan ® Reverse
Transcription Reagents master mix (Applied Biosystems, Foster City, USA) was added to the denatured RNA to a final volume of 20 μl, incubated for 25°C for ten min, and then heated to either 42, 47 or 52°C for 30 min, before the temperature was raised to 95°C for five min.
Linear regression equations for each dilution series were obtained. A univariate analysis of variance (ANOVA) was used to perform a two factor ANOVA -slope and intercept of the linear regressions were used as the dependent variables and denaturation method and temperature of the reverse transcription (RT) as fixed factors.
Addition of one μl 50 μM random hexamers (Applied Biosystems) to dsRNA before denaturation was compared to denaturation of dsRNA alone (in this case the random hexamers were included in the RT-master mix). Subsequent to this experiment, denaturation of dsRNA (together with random hexamers) by heating to 98°C for five min was compared to denaturation at 95°C for one min.
Reverse transcription
Different RT kits were evaluated by extracting dsRNA from three tissue culture (BHK- was performed according to the manufacturer's instructions using random hexamers.
PCR was performed using the VP7 assay and linear regression equations for each dilution series were obtained.
Using Reverse Transcription Reagents (Applied Biosystems), RT of a ten-fold serial dilution series (10 -0 -10 -7
) of dsRNA was performed using both random hexamers 3 and gene specific primers (final concentration of 200 nM, primers were the same as those used in the real-time PCR assay) and the results compared.
Using Reverse Transcription Reagents (Applied Biosystems) and random hexamers, RT was performed for 30 and 60 min on positive field samples of AHSV and results compared.
PCR kits
Fourteen naturally AHSV-infected blood samples were reverse transcribed with both Applied Biosystems Reverse Transcription Reagents (42°C for 30 min and 95°C for 5 min) and High Capacity RNA-to-cDNA Master Mix (37°C for 60 min, 95°C for 5 min).
The cDNA was used in a two-step RT-PCR assay to evaluate different Applied Biosystems PCR kits: TaqMan ® Gene Expression Master Mix, TaqMan ® TaqMan ® Universal PCR Master Mix and Fast Universal PCR Master Mix (used according to the manufacturer's instructions). A further comparison between the latter two kits was then performed using 15 naturally AHSV-infected blood samples.
Gene specific primer concentrations were optimised by testing eight naturally AHSVinfected blood samples with a final primer concentration of 900, 300 and 50nM in the PCR reactions.
Gene specific probe concentrations were optimised by testing eight naturally AHSVinfected blood samples with a final probe concentration of 250, 150 and 50nM in the PCR reactions.
Duplexing of the AHSV assay was evaluated by testing 15 naturally AHSV-infected blood samples with VP7 and NS2 assays, and comparing the results to those obtained from a duplex assay containing the VP7 and the NS2 primers and probes in the same reaction.
Results
Processing blood samples
A paired t-test detected no significant differences [p = 0.504 (VP7 assay) and 0.257 (NS2 assay)] in C T between processing fresh [ x = 30.05, n = 11 (VP7 assay); x = 4 28.40, n = 10 (NS2 assay)] and frozen [ x = 29.75 (VP7 assay) and 27.85 (NS2 assay)] blood. It was decided to freeze blood samples, as they could be stored until analysed and the method was shorter.
RNA extraction kits
ANOVA showed that there was a 1.3 fold increase in amount of AHSV detected when heat, instead of MMOH, was used to denature the dsRNA and the efficiency of the assay increased from 93% to 100%. The difference appeared to be greater at low virus concentrations.
Temperature of the RT significantly accounted for the variation of the slopes [p < 0.001 (VP7 assay) and p = 0.503 (NS2 assay)], but not the intercepts (p > 0.127) of the linear regression equations. The significant result was due to the poor efficiency of the VP7 assay at 47°C. Results obtained from heat-denatured RNA showed that the efficiency of the VP7 assay at 42, 47 and 52°C was 100, 93 and 98%
respectively; for the NS2 assay it was 90, 90 and 87%. The optimum temperature of the RT was therefore 42°C.
The addition of random hexamers to dsRNA before denaturation resulted in 18-fold higher detection of AHSV (a mean decrease in C T of 4.16) compared to the addition of random hexamers after denaturation (paired T-test: p = 0.001, n = 12). Excluded from this test were two samples with a low level of AHSV which tested negative when random hexamers were added after denaturation.
A paired T-test detected a significant difference in C T when dsRNA was denatured at 98°C for five min compared to 95°C for one min [ x difference = 0.370, p = 0.003, n = 13 (VP7 assay) and
x difference = 0.345, p < 0.001, n = 13 (NS2 assay)]. The latter resulted in lower C T values and was therefore a more sensitive method for detecting AHSV.
Reverse transcription
One-way ANOVA showed no significant differences (p > 0.284) in the slopes nor the intercepts of the regression equations derived from using the different RT kits.
However, the C T -values obtained from using the Applied Biosystems and Ambion kits were on average 1.79 and 1.99 (n = 19) lower compared to the results obtained from the Roche kit. In addition, C T versus log concentration plots showed that the data were more sigmoidal in shape than linear when the Roche kit was used, indicating inhibition of the RT reaction at high RNA concentrations, which was not evident in the data obtained from the other kits. Of the three kits, the Roche kit was judged to have performed the worst, while no differences between the Applied Biosystems and Ambion kits were detected. The Applied Biosystems kit was chosen based on costs.
When the RNeasy Mini Kit was used to extract RNA from washed and pelleted RBC membranes (500 μl starting volume), a mean RNA concentration of 29.8 ng/μl (s = 22.8, n = 15, elution volume = 30 μl) was measured in the eluate. With Reverse Transcription Reagents (Applied Biosystems), up to 500 ng RNA can be reverse transcribed in a 20 μl reaction. The maximum volume of RNA (7.7 ul) was therefore used in the RT reaction.
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Using random hexamers instead of gene-specific primers in the RT step resulted in C T 's that were on average 0.27 (n = 12) lower and the detection limit was 100-fold lower (10 6 and 10 4 -fold dilution for random hexamers and gene specific primers respectively) and was therefore a more sensitive method.
A paired T-test detected a significant difference in C T when the length of the RT was increased from 30 min to 60 min for the VP7 assay ( x difference = 0.747, p < 0.001, n = 13) but not for the NS2 assay (
x difference = 0.081, p = 0.285, n = 13), suggesting a selective increase in VP7 cDNA, but not NS2 cDNA when the length of the RT was increased.
PCR kits
There were significant differences in C T 's between the High Capacity RNA-to-cDNA 
